Natural Product: NPC183283

Natural Product IDNPC183283
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Lucialdehyde C
IUPAC Name (6R)-6-[(3S,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-7-oxo-1,2,3,5,6,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanal
Synonyms Lucialdehyde C
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL470979
PubChem CID 44575605
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey ZLINFWYHFGTJCG-WVKDCGJFSA-N
Standard InCHI InChI=1S/C31H48O3/c1-19(21(3)18-32)9-10-20(2)22-11-16-31(8)27-23(12-15-30(22,31)7)29(6)14-13-26(34)28(4,5)25(29)17-24(27)33/h18,20-22,25-26,34H,1,9-17H2,2-8H3/t20-,21?,22-,25?,26+,29-,30-,31+/m1/s1
SMILES O=CC(C(=C)CC[C@H]([C@H]1CC[C@@]2([C@]1(C)CCC1=C2C(=O)CC2[C@]1(C)CC[C@@H](C2(C)C)O)C)C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   468.36 Volume:   526.331
?
Van der Waals volume.
Dense:   0.89 LogP:   4.34
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.75
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.144
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   23.0
TPSA:   54.37
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   1.0 Rings:   4.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.335 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.017 Fsp3:   0.806
MCE-18:   82.5
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.948 Fluc inhibitor:   0.004
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.01
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.004
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.49 Promiscuous compounds:   0.079

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.009 MDCK Permeability:   -4.657
Pgp-inhibitor:   0.31 Pgp-substrate:   0.023
PAMPA:   0.705
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.557 30% Bioavailability (F30%):   0.634
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.427 MRP1:   0.903
Plasma Protein Binding (PPB):   94.083% Volume Distribution (VD):   -0.021
Fu: 6.96%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.999 BCRP inhibitor:   0.576
BSEP inhibitor:   0.871

ADMET: Metabolism

CYP1A2-inhibitor:   0.004 CYP1A2-substrate:   0.528
CYP2C19-inhibitor:   0.976 CYP2C19-substrate:   0.854
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.018
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.619
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.016 CYP2C8-inhibitor:   1.0
HLM stability:   0.304
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  11.124 Half-life (T1/2):  0.296

ADMET: Toxicity

hERG Blockers:  0.022 hERG Blockers (10um):  0.17
Human Hepatotoxicity (H-HT):  0.605 Drug-induced Liver Injury (DILI):  0.073
AMES Toxicity:  0.309 Rat Oral Acute Toxicity:  0.259
Maximum Recommended Daily Dose:  0.654 Skin Sensitization:  0.971
Carcinogencity:  0.76 Eye Corrosion:  0.047
Eye Irritation:  0.756 Respiratory Toxicity:  0.725
Drug-induced Neurotoxicity:  0.062 Ototoxicity:  0.639
Hematotoxicity:  0.504 Drug-induced Nephrotoxicity:  0.727
Genotoxicity:  0.699 RPMI-8226 Immunitoxicity:  0.054
A549 Cytotoxicity:  0.284 Hek293 Cytotoxicity:  0.407
BCF:   1.934
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.658
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.1
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.526
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. DOI[10.1016/j.phytochem.2005.10.025]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[11520245]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[12045343]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[14695801]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[1791484]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. spore n.a. PMID[18827358]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies Nagano, Japan 2008-MAY PMID[20039640]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[20384295]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies n.a. n.a. PMID[20702092]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies n.a. n.a. PMID[21924611]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[22014750]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[22044278]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting body n.a. n.a. PMID[22047696]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[26222905]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[9635497]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO32479 gleophyllum lucidum Species n.a. n.a. n.a. n.a. n.a. Database[Title]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1317 Cell line CCRF S-180 Mus musculus ED50 = 7.1 ug ml-1 PMID[14987072]
NPT396 Cell line T47D Homo sapiens ED50 = 4.7 ug ml-1 PMID[14987072]
NPT1317 Cell line CCRF S-180 Mus musculus IC50 = 7.1 ug.mL-1 PMID[23092389]
NPT396 Cell line T47D Homo sapiens IC50 = 4.7 ug.mL-1 PMID[23092389]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. ED50 = 3.8 ug ml-1 PMID[14987072]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. ED50 = 10.7 ug ml-1 PMID[14987072]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 10.7 ug.mL-1 PMID[23092389]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 3.8 ug.mL-1 PMID[23092389]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC183283 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8103 Intermediate Similarity NPC110021
0.8103 Intermediate Similarity NPC482426
0.7377 Intermediate Similarity NPC275740
0.7377 Intermediate Similarity NPC86319
0.7097 Intermediate Similarity NPC482424
0.7031 Intermediate Similarity NPC69454
0.6984 Remote Similarity NPC259286
0.6984 Remote Similarity NPC83216
0.6984 Remote Similarity NPC484085
0.6935 Remote Similarity NPC482423
0.6774 Remote Similarity NPC131470
0.6724 Remote Similarity NPC482425
0.6716 Remote Similarity NPC601194
0.6129 Remote Similarity NPC118508
0.5676 Remote Similarity NPC489808
0.5676 Remote Similarity NPC489800
0.5625 Remote Similarity NPC484086
0.5588 Remote Similarity NPC99909
0.5588 Remote Similarity NPC249954
0.5522 Remote Similarity NPC143767
0.5417 Remote Similarity NPC484971
0.5417 Remote Similarity NPC484970
0.5352 Remote Similarity NPC191684
0.5342 Remote Similarity NPC482518
0.5294 Remote Similarity NPC471724
0.5075 Remote Similarity NPC46160
0.5075 Remote Similarity NPC202642

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC183283 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data